Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Phathom Pharmaceuticals (PHAT) Return on Equity: 2022-2025

Historic Return on Equity for Phathom Pharmaceuticals (PHAT) over the last 3 years, with Sep 2025 value amounting to 0.66%.

  • Phathom Pharmaceuticals' Return on Equity fell 95.00% to 0.66% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.66%, marking a year-over-year decrease of 95.00%. This contributed to the annual value of 2.05% for FY2024, which is 68.00% down from last year.
  • As of Q3 2025, Phathom Pharmaceuticals' Return on Equity stood at 0.66%, which was down 25.30% from 0.89% recorded in Q2 2025.
  • Over the past 5 years, Phathom Pharmaceuticals' Return on Equity peaked at 5.09% during Q2 2023, and registered a low of 0.66% during Q3 2025.
  • Its 3-year average for Return on Equity is 2.15%, with a median of 1.58% in 2024.
  • Its Return on Equity has fluctuated over the past 5 years, first surged by 55bps in 2023, then tumbled by 354bps in 2024.
  • Phathom Pharmaceuticals' Return on Equity (Quarterly) stood at 3.90% in 2022, then surged by 55bps to 4.45% in 2023, then crashed by 293bps to 1.52% in 2024, then tumbled by 95bps to 0.66% in 2025.
  • Its Return on Equity stands at 0.66% for Q3 2025, versus 0.89% for Q2 2025 and 1.17% for Q1 2025.